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cDNA clones for 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase were isolated from rat liver expres- 
sion libraries in 2gtl I by antibody, oligonucleotide, and cDNA screening. One 1860 bp long clone contained 
a full-length nucleotide sequence coding for the 470 amino acids of each of the two identical subunits of 
the bifunctional enzyme. This clone also contained untranslated sequences, one 173 bp long upstream from 
the ATG start codon and one 271 bp long downstream from the TGA stop codon. The clone was terminated 
by a poly(A) tail of 29 nucleotides. 
cDNA; 6-Phosphofructo-2-kinase; Fructose-2,6-bisphosphatase; (Rat liver) 
1. INTRODUCTION 
Fructose 2,6-bisphosphate has been identified in 
all eukaryotic tissues and is a potent stimulator of 
6-phosphofructo-l-kinase. Its synthesis and 
degradation are catalysed by 6-phosphofructo- 
2-kinase (EC 2.7.1.105; PFK-2) and fructose 
2,6-bisphosphatase (EC 3.1.3.46; FBPase-2), 
respectively. In rat liver, both reactions are catalys- 
ed at separate sites on the same 55 kDa polypep- 
tide chain, two of which make up the native 
bifunctional enzyme (reviews [1,2]). In purified en- 
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zyme preparations, the PFK-2/FBPase-2 activity 
ratio of the heart enzyme is at least one order of 
magnitude greater than that of the liver enzyme, 
whereas the muscle enzyme contains more bisphos- 
phatase than kinase activity. Indeed, these and 
other data suggest he existence of isozymes [3,4]. 
Liver PFK-2/FBPase-2 is a substrate of the cAMP- 
dependent protein kinase which activates the 
bisphosphatase and inactivates the kinase as a 
result of protein phosphorylation. In HTC cells, 
PFK-2 activity is increased by glucocorticoids [5], 
while in chick embryo fibroblasts, PFK-2 is ac- 
tivated by growth factors, phorbol esters [6], and 
tyrosine-specific oncogenic protein kinases [7]. As 
a first step in the understanding of the structure- 
activity relationships for the PFK-2/FBPase-2 
isozymes and to study their regulation we have 
undertaken the present work. We report here the 
complete nucleotide sequence of the rat liver 
bifunctional enzyme derived from cDNA clones. 
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00145793/87/$3.50 © 1987 Federation of European Biochemical Societies 317 
Volume 224, number 2 FEBS LETTERS 
1 CAN~GAGGGAGCT GGAGATAATCT GT GAGAG6CT CCGAAGCCCAGTACAT CCCCCT GACT CAGC 
66 CCT GCCCACCT GCT GCTGTGACTACAGCAACAGACAAGACAGCTAC-GAAGATAGGAAGT GAGGT CC 
152 MTACCT T GT GGGCAGTOOT OT CAT TAGCT(3CAACGCCTAAG~"G,T CT COAOAOATOOOA(]AACT C 
S R E M G E L 7 
i98 ACT CAAACCAGGT TACAGAAGATCTGGAT T CCACACAGCAGCAGTAGCAGCGT GCT GCAACGGCGA 
T Q T R L Q K I W I P H S S S S S V L (~ R R 29 
264 AGGGGCT CCT CCATACCACAGTTCACTAATTCTCCCACGATGGTGATCATGGTGGGTTTACCAGCT 
P., 0 S S I P O F T N S P T M V I M V 0 L P A 5i 
330 CGAGGCAAGACCTACATCTCTACGAAGCT CACACGCTATCTCAACTGGATAGGAACACCAACTAAA 
R G K T Y I S T K L T R Y L N W I 13 T P T K 73 
396 GTGTTTAATTTAGGTCAGTATCGACGAGAGGCAGTGAGTTACAGGAACTATGAATTCTTTCGCCCA 
V F N L G Q Y R R E A V G Y R N Y E F F R P 95 
462 GACAACACAGAGGCCCAGCT AT CAGGAAGCAGT GT GCT CTAGCAGCCCTAAAGGATGT CCATAAG 
D I',1 T E A Q L I R K Q C A L A A L K D V H K 117 
528 TATCT CAGCCGCGAGGAAGGT CAT GT T GCGGT T T T T GAT GCCACCAACACTACCAGAGAACGACGA 
Y L G R E E G H V A V F D A T N T T R E R R 139 
594 TCGT TGAT TCTACAGTT TGCTAAGGAACATGGTTATAAGGTCTTCTTTATTGAGTCTATTTGTAAT 
S L I L O F A K E H (3 Y K Y F F I E $ I C N 161 
660 GACCCCGAAAT CAT T GCAGAAAACAT CAAGCAAGT GAAACT T GGIAGT CCT GAT TACA'I'AGACI'GT 
D P E I I A E N I K Q V K L G 5 P D Y I D C 183 
726 GACCAAGAAAAGGT  T TGGAAGACT T T CTAAAGAGAATAGAGT GCTAT GAGAT CAACTACCAACCT 
D Q E K V L E D F L K R I E C Y E I N Y Q P 205 
792 T T GGAT GAGGAAT T GGACAGCCACCT GT CCTACAT CAAGAT CT T C6ACGT GGGCACACGCTACAT G 
L D E E L D S H L S Y I K I F D V G T R Y M 227 
858 GTAAAT CGAGT GCAGGACCACGTT CAGAGCCGTACAGCCTACTACCT CAT GAACATCCATGT CACA 
V N R V Q D H V Q S R T A Y Y L M N I H V T 249 
924 CCT CGATCTAT CTACCTAT(3CC(3CCAT OOTGAGAGT GAACT CAACCTTAOA(3GCCGCAT T GGAI30T 
P R S I Y L C R H (3 E S E L N L R 0 R I (3 (3 271 
990 GACT CTG(3CCT CT CAGCT COGGOCAAGCA(3TAT GCCTATGCACTAGCCAACT T CATCCGGT CT CAA 
D S 0 L S A R (3 K Q Y A Y A L A N F I R S Q 293 
I056 GGCAT CAGCT CCCT GAAAGTAT OGACTAGCCACATGAAGAGOACCAT T CAGACCGCT GAAOCCCTA 
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@ I $ S L K Y W T 5 H H K P T I q T A E A L 315 
1121 OGTGTCCCCTATGAACAOTOOAAGGCCCTOAATC~GATTGATOCOOOTOTCTOTOAAOAOATOACC 
O V P Y E Q W K A L N E I D A 0 V C E E M T 337 
1188 TATGAAOAAATTCAGGAACACTACCCTOAGGAATTTOCACTACGGGACCAOGATAAATATCGTTAC 
Y E E t Q E H Y P E E F A L R D Q D K Y R Y 359 
1254 COCTATCCCAAOGGAGAGTCCTATGAOGAT CTGOT TCAGCGTCT T GAACCAGT TATMTGGAOCTA 
R Y P K G E S Y E D L V Q R L E P V I M E L 381 
1320 ON~COOCAAGAAAATOTACTOGTGATCTOTCACCAOOCTOTCATOCOOTOCCTCCTGOCATACT TC 
E R Q E N V L V I C H Q A V M R C L L A Y F 403 
1386 CTOGATAAAAOTTCAGATGA(~CTGCCCTATCTCAAOT(~TCCTCTGCATACTOTGCTCAAACTCACA 
L D K S S D E L P Y L K C P L H T V L K L T 425 
1452 CCTGTGGCTTATGOCTOCAGAGTGC~GTCCATCTACCTGAATGTGGAGGCTGT GAACACACACCOG 
P V A Y G C R V E S I Y L N V E A V N T H R 447 
1518 GACAAGCCTOAGAATGTGGACATCACCCOTGAAGCTGAGGAAGCCTTGGACACTGTACCTGCCCAT 
D K P E N V D I T R E A E E A L D T V P A H 469 
1584 TAC,TGA,C-CCCTT T CAAGTGATCAGAT TOT CT CTGTTCTCACCCCCT T CCT CCT GTAGOAGCT GCT 
Y_ 470 
1650 GCCCTTGTTCTCCTTAAGCAGACTCTGGCTATGGCCTGAGAGTGCCCTACCTCCAOTGN~GN~GTC 
1716 CGTAGCAGCTCCCAAACAGGTCTCAATTCCTAGCCACAACTAAGGCACCTACCTAGTTGTGGATM 
1782 AOTTCCTTTTAAATATTCTCTOATAAATAAAGATOTTTATTTCTOCCTATA(29) 
Fig.1. Nucleotide sequence of clone RL2K-22C and amino acid sequence derived for rat liver PFK-2/FBPase-2. Each 
amino acid is aligned with the first letter of the corresponding codon. Numbers on the left refer to nucleotides, those 
on the right to amino acids. The polyadenylation signal and the sequenced tryptic peptides are underlined. Boxes 
indicate the translation i itiation and stop codons. The nucleotide sequence shown has been obtained either from both 
cDNA strands of appropriate fragments, or from one strand and confirmed by sequencing the corresponding fragments 
of clones RL2K-4C and (or) -5C. The 100 bp ]ong sequence at the 5'-end of the clone has been obtained in the 5' to 
3' direction. 
2. EXPERIMENTAL 
PFK-2/FBPase-2 was purified as described [8,9] 
from the livers of 25 male Wistar rats. The method 
includes two precipitation steps with polyethylene 
glycol followed by chromatography on DEAE- 
Trisacryl and Blue Sepharose. This yielded 2.3 mg 
protein (42 mU/mg) and showed one major 
55 kDa band after SDS-PAGE. Rabbits were in- 
jected with the material eluted from this band and 
polyclonal antibodies against denatured PFK-2/ 
FBPase-2 were raised. 300#g PFK-2/FBPase-2 
were digested with trypsin and the fragments 
separated by reversed-phase HPLC on a C-4 col- 
umn. Nine peptides were selected for microse- 
quencing using a gas-phase sequenator (Applied 
Biosystems, USA). Oligonucleotides based on the 
microsequence were purchased from Eurogentec 
(Libge, Belgium). Two rat liver cDNA expression 
libraries in Agtll were screened. One, from a 
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Sprague-Dawley female rat, was purchased from 
Clontech. The other library (JNO library) was 
prepared from male Wistar rat poly(A)-containing 
RNA by oligo(dT) priming as in [10]. Phage and 
plasmid DNA was prepared [11] and M13 dideoxy 
sequencing was performed as described [12] using 
a kit from Amersham. Enzymes were purchased 
from BRL or Boehringer. 32p-nucleotides were 
from Amersham. 1 x SSC solution contained 
0.15 M NaCI and 0.015 M sodium citrate. 
3. RESULTS AND DISCUSSION 
3.1. Isolation of a partial cDNA clone 
The antiserum used (IRL-5) was specific for 
PFK-2. First, it gave at 1 : 1500 dilution a positive 
ELISA signal with 1 ng native or denatured rat 
liver PFK-2 spotted onto nitrocellulose. Second, 
by Western blotting, it detected a single band at 
55 kDa after SDS-PAGE of rat liver cytosol and a 
single spot after isoelectrofocusing in the second 
dimension. Third, this antiserum precipitated 
PFK-2 activity of rat liver cytosol in the presence 
of protein A-Sepharose. None of these effects were 
observed with nonimmune rabbit serum. The 
Clontech library was titrated in strain Y1090 and 
5.6 x 105 recombinant clones were screened [13] 
with antiserum IRL-5 at 1 : 600 dilution preadsorb- 
ed on a Y1090 lysate, and revealed with a 
peroxidase-coupled anti-rabbit IgG antibody 
(BioRad). Three clones remained positive at the 
tertiary screening. The three clones (henceforth 
called RL2K-8) were identical because they had the 
same length (about 1100 bp), cross-hybridized in
Southern blots, and displayed the same restriction 
pattern with BgllI, PstI and RsaI. 
Microsequencing of PFK-2/FBPase-2 yielded 
nine peptides. Based on codon usage frequency 
[14] a 16 amino acid long peptide was used to con- 
struct a 47-mer oligonucleotide probe (5'- 
TTCCACTGCTCATATGGCACGCCCAGGGC-  
CTCAGCTGTCTGGATGGT).  This served to 
confirm the identity of clone RL2K-8 by in situ 
hybridization of bacteriophage plaques [11]. The 
47-mer probe hybridized with RL2K-8 DNA in 
conditions (hybridization in 2 x SSC, 50°C; 
washings in 1 × SSC, 50°C) under which it did not 
hybridize with nonrecombinant DNA or with four 
unrelated clones. Further evidence that RL2K-8 
was specific for PFK-2/FBPase-2 stemmed from 
the finding (see below) that it was identical to the 
PFK-2 clone obtained recently by Colosia et al. 
[15] from the same cDNA library. 
3.2. Characterization of a full-length cDNA 
Since clone RL2K-8 was too short to code for 
the entire PFK-2/FBPase-2 sequence, more clones 
were searched for by screening another rat liver 
cDNA library (JNO) with RL2K-8 after recloning 
in the EcoRI site of pBR322. From 5.4 x l0 s 
recombinant clones, 11 were positive at the tertiary 
screening. Two of them, RL2K-4C and -5C, are 
currently being characterized. Clone RL2K-22C, 
which is 1860 bp long, was recloned in pBR322 
and digested with EcoRI, PstI and BgllI to yield 
fragments uitable for subcloning in the M13 vec- 
tor [16], and sequencing. The sequence of clone 
RL2K-22C is shown in fig.1. It extends from 
173 bp upstream from the translation initiation 
site to a 29-mer poly(A) tail located 242 bp 
downstream from the TGA stop codon. The 
poly(A) tail is preceded by a poly(A) signal 
AATAAA 20 bp upstream. The ATG start site is 
preceded by a sequence compatible with the 
(C)(C)A(C)(C)ATG(G) consensus proposed [17] 
for translation initiation signals. The 1086 bp 
clone RL2K-8 spans from nucleotide 675 (amino 
acid 167) to 1760 (171 bp beyond the stop signal) 
of clone RL2K-22C. The 1410 bp translated se- 
quence of clone RL2K-22C codes for a 470 amino 
acid protein of M, 54570. The corresponding 
nucleotide sequence is identical to that of Colosia 
et al. [15] except for nucleotide 1262 which is C in- 
stead of G. All nine peptides, 113 amino acids 
altogether, derived from the sequence are found 
within this protein. Their position is shown in 
fig.1. The 47-mer probe corresponded to amino 
acids 308-323 and was 83% homologous to the ac- 
tual nucleotide sequence. A search of the EMBL 
databank (release no. l l ,  April 1987) revealed no 
homology greater than 60% with known 
nucleotide sequences. Northern blot analysis of 
poly(A)-containing RNA from rat liver yielded a 
major band corresponding to an mRNA about 
2150 nucleotides long. Thus, the 5'-untranslated 
portion of PFK-2 mRNA is about 500 bp long. 
The amino acid sequence obtained from the 
purified protein by Colosia et al. [15] is identical to 
that deduced from the nucleotide sequence shown 
in fig. I, except for amino acids 134 (Tyr instead of 
320 
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Thr) and 137 (Phe instead of Glu). Whether this is 
due to a difference in rat strain (Wistar in fig.1 vs 
Sprague-Dawley in [15]) is not known. As the 
NH2-terminal residue was previously identified as 
a blocked serine, the initiator methionine is re- 
moved prior to the final blocking of the protein. 
Three functional domains of the protein can be 
tentatively identified (see [15] for discussion). The 
PFK-2 domain contains the three cysteines at 
amino acid positions 160, 183 and 198. These three 
cysteinyl residues are clustered together in a 
38-residue CNBr fragment which may be impor- 
tant in maintaining the conformation of the PFK-2 
sugar phosphate binding site [18]. The FBPase-2 
domain contains the critical histidyl residue 258. 
The third domain, near the amino-terminus, con- 
tains the site of phosphorylation (Ser 32) by the 
cAMP-dependent protein kinase. This site is im- 
mediately preceded by the sequence Arg-Arg-Gly 
which is typical [19] for conferring specific 
recognition by this kinase. Rat liver PFK-2 con- 
tains no consensus equence [20] for recognition 
by protein kinase C, an enzyme that phosphory- 
lates heart, but not liver PFK-2 [3]. However, 
the sequence 352-359 contains residues 
(Arg.X.X.Asp.X.X.X.Tyr) that could confer 
specific recognition by tyrosine-specific protein 
kinases [20]. The RL2K-22C clone should allow 
one to identify the transcription initiation site, to 
characterize the PFK-2 isozymes and mRNAs, to 
clone the corresponding gene(s), and to study their 
regulation. 
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